The Nucleocapsid Protein of SARS-CoV-2: a Target for Vaccine Development

被引：270
|
作者：
Dutta, Noton K. [1 ]
Mazumdar, Kaushiki [2 ]
Gordy, James T. [3 ]
机构：
[1] Johns Hopkins Univ, Sch Med, Dept Med, Ctr TB Res, Baltimore, MD 21205 USA
[2] Univ Maryland, Sch Med, Ctr Vaccine Dev & Global Hlth, Baltimore, MD 21201 USA
[3] Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD USA
来源：
JOURNAL OF VIROLOGY | 2020年 / 94卷 / 13期
关键词：
coronavirus disease 2019 (COVID-19); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); nucleocapsid protein; vaccine; SARS-CORONAVIRUS; GENOME SEQUENCE; NEUTRALIZATION; ANTIBODIES; VIRUS;
D O I：
10.1128/JVI.00647-20
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] N-terminally truncated nucleocapsid protein of SARS-CoV-2 as a better serological marker than whole nucleocapsid protein in evaluating the immunogenicity of inactivated SARS-CoV-2
    Yue, Lei
    Cao, Han
    Xie, Tianhong
    Long, Runxiang
    Li, Hua
    Yang, Ting
    Yan, Min
    Xie, Zhongping
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (03) : 1732 - 1738
  • [42] SARS-CoV-2 Spike Protein Extrapolation for COVID Diagnosis and Vaccine Development
    Malik, Yashpal S.
    Kumar, Prashant
    Ansari, Mohd Ikram
    Hemida, Maged G.
    El Zowalaty, Mohamed E.
    Abdel-Moneim, Ahmed S.
    Ganesh, Balasubramanian
    Salajegheh, Sina
    Natesan, Senthilkumar
    Sircar, Shubhankar
    Safdar, Muhammad
    Vinodhkumar, O. R.
    Duarte, Phelipe M.
    Patel, Shailesh K.
    Klein, Jorn
    Rahimi, Parastoo
    Dhama, Kuldeep
    [J]. FRONTIERS IN MOLECULAR BIOSCIENCES, 2021, 8
  • [43] Comparison of the SARS-CoV-2 spike protein ELISA and the Abbott Architect SARS-CoV-2 IgG nucleocapsid protein assays for detection of antibodies
    Wadhwa, Ashutosh
    Yin, Sherry
    Freeman, Brandi
    Hershow, Rebecca B.
    Killerby, Marie
    Yousaf, Anna R.
    Lester, Sandra
    Mills, Lisa
    Buono, Sean A.
    Pomeroy, Mary
    Owusu, Daniel
    Chu, Victoria T.
    Tate, Jacqueline E.
    Bhattacharyya, Sanjib
    Hall, Patricia
    Thornburg, Natalie J.
    Kirking, Hannah L.
    [J]. PLOS ONE, 2021, 16 (07):
  • [44] HIV and SARS-CoV-2 Pathogenesis and Vaccine Development
    Fleury, Herve
    [J]. VIRUSES-BASEL, 2022, 14 (12):
  • [45] Development of an inactivated vaccine candidate for SARS-CoV-2
    Gao, Qiang
    Bao, Linlin
    Mao, Haiyan
    Wang, Lin
    Xu, Kangwei
    Yang, Minnan
    Li, Yajing
    Zhu, Ling
    Wang, Nan
    Lv, Zhe
    Gao, Hong
    Ge, Xiaoqin
    Kan, Biao
    Hu, Yaling
    Liu, Jiangning
    Cai, Fang
    Jiang, Deyu
    Yin, Yanhui
    Qin, Chengfeng
    Li, Jing
    Gong, Xuejie
    Lou, Xiuyu
    Shi, Wen
    Wu, Dongdong
    Zhang, Hengming
    Zhu, Lang
    Deng, Wei
    Li, Yurong
    Lu, Jinxing
    Li, Changgui
    Wang, Xiangxi
    Yin, Weidong
    Zhang, Yanjun
    Qin, Chuan
    [J]. SCIENCE, 2020, 369 (6499) : 77 - +
  • [46] SARS-CoV-2 vaccine candidates in rapid development
    Li, Lifeng
    Guo, Pengbo
    Zhang, Xiaoman
    Yu, Zhidan
    Zhang, Wancun
    Sun, Huiqing
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (03) : 644 - 653
  • [47] Platforms Exploited for SARS-CoV-2 Vaccine Development
    Mathew, Shilu
    Faheem, Muhammed
    Hassain, Neeraja A.
    Benslimane, Fatiha M.
    Al Thani, Asmaa A.
    Zaraket, Hassan
    Yassine, Hadi M.
    [J]. VACCINES, 2021, 9 (01) : 1 - 24
  • [48] Development of SARS-CoV-2 Vaccine: Challenges and Prospects
    Mahboob, Tooba
    Ismail, Amni Adilah
    Shah, Muhammad Raza
    Rahmatullah, Mohammed
    Paul, Alok K.
    Pereira, Maria de Lourdes
    Wiart, Christophe
    Wilairatana, Polrat
    Rajagopal, Mogana
    Dolma, Karma G.
    Nissapatorn, Veeranoot
    [J]. DISEASES, 2023, 11 (02)
  • [49] SARS-CoV-2 Vaccine Development: Current Status
    Poland, Gregory A.
    Ovsyannikova, Inna G.
    Crooke, Stephen N.
    Kennedy, Richard B.
    [J]. MAYO CLINIC PROCEEDINGS, 2020, 95 (10) : 2172 - 2188
  • [50] The Improbability of the Rapid Development of a Vaccine for SARS-CoV-2
    Morris, Kevin V.
    [J]. MOLECULAR THERAPY, 2020, 28 (07) : 1548 - 1549
12345